NEW YORK--(BUSINESS WIRE)--PIN Pharma, a pre-IND immunotherapy company focused on oncology, today announced the Company will be presenting a poster (B080) on Friday, September 18, 2015 from 4:45 pm – 6:45 pm entitled, PIN-2, A Novel Immunomodulatory Peptide.
About PIN Pharma, Inc.
PIN Pharma is a pre-IND stage venture backed immunotherapy company focused on the development of PINS (precision immune stimulants). The lead compound PIN-2 is a first-in-class, novel, next-generation engineered peptide that empowers the immune system in vivo.
Help employers find you! Check out all the jobs and post your resume.
